Home > > > > Report Detail

2019 Emerging Nucleic Acid Testing (NAT) Assays, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers

Publisher Name :
Date: 02-May-2019
No. of pages: 549

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products.  

This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 549 pages and 22 tables

2019 Emerging Nucleic Acid Testing (NAT) Assays, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers

Table of Contents

Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
* AIDS
O Structure and Composition
O Classification
O AIDS Origins
O Animal Lentivirus Systems
O Virus Receptors
O HIV Infections in Humans
- Pathogenesis and Pathology
O CD4T Lymphocytes and Memory Cells
O Monocytes and Macrophages
O Lymphoid Organs
O Neural Cells
O Viral Coinfections
- Clinical Findings
O Plasma Viral Load
O Pediatric AIDS
- Neurologic Disease
- Opportunistic Infections
- Cancer
O Immunity
- Virus Isolation
- Serology
- Viral Nucleic Acid/Antigen Detection
O Epidemiology
- Worldwide Spread of AIDS
- United States
- Routes of Transmission
O DNA Probes
- Overview
- Quantitative PCR
- In Situ PCR
- Needed Improvements
O Viral Load/Drug Resistance Testing
O Genotype and Phenotype Testing
O Blood Banking Considerations
* Adenovirus
O Background
O Diagnostic Tests
O Vaccines and Drugs
O Adeno-Associated Viruses (AAV)
* Anthrax/Bacillus Anthracis
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Babesiosis
O Background
* BEA and Other Bartonella Diseases
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Chagas Disease
O Background
* Campylobacter
O Background
O Diagnostic Tests
- Culture Identification
O Vaccines and Drugs
* Chlamydia
O Background
- Chlamydia psittaci
- Chlmaydia pneumoniae
- Chlamydia trachomatis
O Diagnostic Tests
O Vaccines and Drugs
* Creutzfeldt-Jakob's Disease
O Background
O Blood Transmission
O Diagnostic Tests
O Major Commercial and Academic Players
- Bayer
- Disease Sciences/Bio Tec Global
- Imperial College School of Medicine
- Ortho-Clinical Diagnostics
- Pall
- ProMetic Life Sciences
- Proteome Sciences/Idexx
- Q-One Biotech
- Serono
- U.S. Agricultural Research Service
O Drugs
O Vaccines
* Cytomegalovirus
O Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
O Diagnostic Tests
O Vaccines and Drugs
* Ebola Virus
O Background
- Epidemiology
- Clinical Syndromes
O Diagnostic Tests
O Vaccines and Drugs
* EchoVirus
O Background
- Acute Aseptic Meningitisis
- Encephalitis
- Exanthems
- Respiratory Disease
- Myopericarditis
- Neonatal Infections
O Diagnostic Tests
O Vaccines and Drugs
* Encephalitis
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Enteroviruses
O Background
O Diagnostic Tests
- Viral Isolation and Identification
- Antibody Tests
O Vaccines and Drugs
* Epstein-Barr Virus
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Gonorrhea
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Hepatitis
O Hepatitis A
O Hepatitis B
- Structure and Composition
- Replication
O Hepatitis C
O Hepatitis D (Delta)
O Hepatitis E
O Hepatitis G
O Hepatitis Infections Pathology
O Clinical Findings
O Laboratory Tests
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatitis E
O Virus-Host Immune Reactions
O Epidemiology
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta)
O Vaccines and Drugs
* Herpes Simplex Virus
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Legionella
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Lyme Disease
O Background
- Clinical Description
- Clinical Case Definition
- Laboratory Criteria for Diagnosis
- Case Classification
O Diagnostic Tests
O Vaccines and Drugs
* Malaria
* Mycoplasma
O Background
- Ureaplasma Urealyticum & Mycoplasma Hominis
O Diagnostic Tests
O Vaccines and Drugs
* Papillomaviruses/HPV
O Background
- HPV in Cancer
- Cervical Neoplasm
O Diagnostic Tests
O Vaccines and Drugs
- Prevention
* Parvovirus B19
O Background
- Microbiology
- Epidemiology
- Clinical Syndromes
- Erythema Infectiosum (Slapped Cheek)
- Adult Polyarthropathy
- Transient Aplastic Crisis
- Transient Pancytopenia
- Red Cell Aplasia in Immunocompromised
- Perinatal Infections
O Diagnostic Test
O Vaccines and Drugs
* Pneumonia
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Polyomaviruses
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Salmonellosis
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Shigellosis
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Streptococci
O Background
O Diagnostic Tests
O Vaccines and Drugs
- Group A Streptococci
- Group B Streptococci
* Toxoplasmosis
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Tuberculosis
O Background
O Diagnostic Tests
- Microscopic Characteristics
- Cultural Characteristics
- Skin Tests
- MDRTB
O Vaccines and Drugs
* West Nile Virus
O Background
- Clinical Syndromes
O Diagnostic Tests
O Vaccines and Drugs
* Yersinia
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Antibiotic Susceptibility
Cancer Testing
a. Overview
b. Major Cancer Types
* Prostate
* Lung
* Colon and Rectum
* Breast
* Skin
* Uterine
* Leukemia
* Oral
c. Oncogenes
O Abl/abl-bcr
O AIB1
O BCL-2
O BRCA1
O CD44
O C-fos
O C-myb
O C-myc
O CYP17
O Erb-B
O HPC1
O N-myc
O P40
O P51
O P53
O PIK3CA
O PTI-1
O Ras
O Reg
O Sis
O Src
Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
* Achondroplasia
* Autosomal Dominant Polycystic Kidney Disease
* Cancer
* Cosmetogenomics
* Cystic Fibrosis
* Down's Syndrome
* Duchenne and Becker Muscular Dystrophy
* Factor V (Leiden)
* Factor IX Deficiency
* Fragile X Syndrome
* Heart Disease
* Hemochomatosis
* Hemophilia
* Huntington's Disease
* Maternal-Fetal Incompatibility
* Multiple Endocrine Neoplasia
* Phenylketonuria (PKU)
* Polycystic Kidney Disease (PKD)
* Prenatal Screening
* Retinitis Pigmentosa
* Retinoblastoma
* Sickle Cell Anemia
* Spinal Muscular Atrophy
* Vitamin B12 Metabolism
i. Social Issues and Concerns
Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
* Multilocus Probes
* Single Locus Probes
* PCR and RFLP
c. The FBI
d. DNA Profile Data Banks
* U.S.A.
* U.K.
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe Market Expansion
* Technology Availability
* Use of Hair as Evidence
h. Wildlife Forensics
Paternity Testing/HLA Typing
Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
Competitive Profiles
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forensics/LabCorp
- Decode Genetics
- Diadexus
- Elitech Group
- Eiken
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher

List of Tables

Major Companies Developing or Marketing AIDS Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma
Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Test For Genetic Diseases
  • Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
    Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309
    “Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......
  • Global Pharmaceutical Testing Services Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102
    Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......
  • Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......
  • Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......
  • Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......
  • Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......
  • Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151
    According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......
  • Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......
  • IVD Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs